Vol 7, No 4 (2021)
Case report
Published online: 2022-01-31
Get Citation

Acanthosis nigricans: usefulness of dermoscopy in differential diagnosis

Dominika Kwiatkowska1, Adam Reich1
·
Forum Dermatologicum 2021;7(4):113-115.
Affiliations
  1. Department of Dermatology, Institute of Medical Sciences, Medical College of Rzeszow University, Rzeszów, Poland

paid access

Vol 7, No 4 (2021)
Dermoscopy – case report
Published online: 2022-01-31

Abstract

Acanthosis nigricans is a skin disease characterized by hyperpigmented plaques, typically located in axillae, groins, inframammary region, neck, and flexor surface of the skin. Numerous systemic disorders may lead to the development of acanthosis nigricans. Here a case of a patient with acanthosis nigricans and tissue resistance to insulin is presented. Moreover, the usefulness of dermoscopy as an additional tool that can help to establish a proper diagnosis is discussed.

Abstract

Acanthosis nigricans is a skin disease characterized by hyperpigmented plaques, typically located in axillae, groins, inframammary region, neck, and flexor surface of the skin. Numerous systemic disorders may lead to the development of acanthosis nigricans. Here a case of a patient with acanthosis nigricans and tissue resistance to insulin is presented. Moreover, the usefulness of dermoscopy as an additional tool that can help to establish a proper diagnosis is discussed.

Get Citation

Keywords

acanthosis nigricans; dermoscopy; insulin resistance

About this article
Title

Acanthosis nigricans: usefulness of dermoscopy in differential diagnosis

Journal

Forum Dermatologicum

Issue

Vol 7, No 4 (2021)

Article type

Case report

Pages

113-115

Published online

2022-01-31

Page views

5569

Article views/downloads

27

DOI

10.5603/FD.2021.0020

Bibliographic record

Forum Dermatologicum 2021;7(4):113-115.

Keywords

acanthosis nigricans
dermoscopy
insulin resistance

Authors

Dominika Kwiatkowska
Adam Reich

References (15)
  1. Araújo LMB, Porto MV, Netto EM, et al. Association of acanthosis nigricans with race and metabolic disturbances in obese women. Braz J Med Biol Res. 2002; 35(1): 59–64.
  2. Hirt PA, Castillo DE, Yosipovitch G, et al. Skin changes in the obese patient. J Am Acad Dermatol. 2019; 81(5): 1037–1057.
  3. Litonjua P, Piñero-Piloña A, Aviles-Santa L, et al. Prevalence of acanthosis nigricans in newly-diagnosed type 2 diabetes. Endocr Pract. 2004; 10(2): 101–106.
  4. Mendes AL, Miot HA, Haddad V. Diabetes mellitus and the skin. An Bras Dermatol. 2017; 92(1): 8–20.
  5. Stuart CA, Gilkison CR, Keenan BS, et al. Hyperinsulinemia and acanthosis nigricans in African Americans. J Natl Med Assoc. 1997; 89(8): 523–527.
  6. Wedge CC, Rootman DS, Hunter W, et al. Malignant acanthosis nigricans. A case report. Ophthalmology. 1993; 100(10): 1590–1592.
  7. Pardeshi SS, Khemani UN, Kamath RR, et al. Therapeutic implications of dermoscopic findings in acanthosis nigricans: A clinical and histopathological study. Dermatol Ther. 2020; 33(6): e14521.
  8. Elmas ÖF, Demirbaş A, Kutlu Ö, et al. Utility of dermatoscopy in the diagnosis of acanthosis nigricans. J Cosmet Dermatol. 2020; 19(12): 3426–3427.
  9. Krueger L, Saizan A, Stein JA, et al. Dermoscopy of acquired pigmentary disorders: a comprehensive review. Int J Dermatol. 2022; 61(1): 7–19.
  10. Patel NU, Roach C, Alinia H, et al. Current treatment options for acanthosis nigricans. Clin Cosmet Investig Dermatol. 2018; 11: 407–413.
  11. Kapoor S. Diagnosis and treatment of Acanthosis nigricans. Skinmed. 2010; 8(3): 161–4; quiz 165.
  12. Badr D, Kurban M, Abbas O. Metformin in dermatology: an overview. J Eur Acad Dermatol Venereol. 2013; 27(11): 1329–1335.
  13. Higgins SP, Freemark M, Prose NS. Acanthosis nigricans: a practical approach to evaluation and management. Dermatol Online J. 2008; 14(9): 2.
  14. Ozdemir M, Toy H, Mevlitoğlu I, et al. Generalized idiopathic acanthosis nigricans treated with acitretin. J Dermatolog Treat. 2006; 17(1): 54–56.
  15. Walling HW, Messingham M, Myers LM, et al. Improvement of acanthosis nigricans on isotretinoin and metformin. J Drugs Dermatol. 2003; 2(6): 677–681.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
phone: +48 58 320 94 94, fax: +48 58 320 94 60, e-mail: viamedica@viamedica.pl